Diabetes Research

Go Get the (Immune Cell) Regulators!

Teaser: Shugo Sasaki, M.D., Ph.D., of the University of British Columbia, wants to make beta cell replacement therapies that are “immune” to attack.
Blog

The shortage of donor beta cells and the need for strong immunosuppressive drugs to prevent immune attack make beta cell replacement available only to people with severe life-threatening unawareness of their low blood sugar, called hypoglycemia. At JDRF, we are taking a new route to beta cell replacement technologies, with the aim to develop an unlimited source of insulin-producing cells without drugs that limit your immune system’s role in fighting off infection.

Subscribe to Diabetes Research